Bruna Amanda Girardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bruna Amanda Girardi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Fernandes Klajn Maycá
Department of Neurology Hospital Universitário de Santa Maria, HUSM Santa Maria Brazil
1 shared publication - Amanda Pedroso dos Santos1 shared publication
- Ana Leticia Fornari Caprara
Neurology Department, Cooper Norcross Health, Camden, NJ 08103, USA, USA
1 shared publication - Carlos Fernando Mello
Graduation Program in Pharmacology, Center of Health Sciences, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil
1 shared publication - Elton Orlandin
Laboratório de Estudos de Lepidoptera Neotropical; Departamento de Zoologia; Universidade Federal do Paraná. P.O. Box 19020; 81531-980 Curitiba; Paraná; Brazil.
1 shared publication - Felipe Vanz
Área das Ciências da Vida e Saúde, Universidade do Oeste de Santa Catarina, Rua José Firmo Bernardi, 1591 - Joaçaba, SC, Brazil, 89600-000
1 shared publication
Latest Publications
- 5 November 2026
- Published by Wiley in Movement Disorders Clinical Practice
Changes in Clinical Outcomes and Peripheral Cytokines during Duloxetine Add‐on Therapy in Parkinson's Disease
Background: Neuroinflammation is implicated in Parkinson's disease (PD), and antidepressants may have anti‐inflammatory and motor benefits. The effects of duloxetine on inflammatory biomarkers and clinical outcomes in PD remain unclear. Objectives: To assess changes in motor symptoms, quality of life, and serum cytokines during add‐on duloxetine treatment in PD. Methods: Seventeen patients with PD without other chronic inflammatory diseases received add‐on duloxetine for 8 weeks in an open‐label, uncontrolled trial. Clinical outcomes included Unified Parkinson's Disease Rating Scale (UPDRS), modified Hoehn and Yahr (HY), and Parkinson's Disease Questionnaire‐39 (PDQ‐39) scores. Serum TNF‐α, IL‐1β, IL‐6, and IL‐10 levels were measured at baseline and follow‐up. Results: UPDRS, activities of daily living, and PDQ‐39 scores decreased during treatment. Ten patients achieved ≥5‐point UPDRS reductions. TNF‐α, IL‐1β, and IL‐6 decreased, whereas IL‐10 increased after treatment. Conclusions: Add‐on duloxetine was associated with changes in clinical outcomes and inflammatory markers in patients with PD.
- 5 November 2026
- Published by Wiley in Movement Disorders Clinical Practice
Changes in Clinical Outcomes and Peripheral Cytokines during Duloxetine Add‐on Therapy in Parkinson's Disease
Background: Neuroinflammation is implicated in Parkinson's disease (PD), and antidepressants may have anti‐inflammatory and motor benefits. The effects of duloxetine on inflammatory biomarkers and clinical outcomes in PD remain unclear. Objectives: To assess changes in motor symptoms, quality of life, and serum cytokines during add‐on duloxetine treatment in PD. Methods: Seventeen patients with PD without other chronic inflammatory diseases received add‐on duloxetine for 8 weeks in an open‐label, uncontrolled trial. Clinical outcomes included Unified Parkinson's Disease Rating Scale (UPDRS), modified Hoehn and Yahr (HY), and Parkinson's Disease Questionnaire‐39 (PDQ‐39) scores. Serum TNF‐α, IL‐1β, IL‐6, and IL‐10 levels were measured at baseline and follow‐up. Results: UPDRS, activities of daily living, and PDQ‐39 scores decreased during treatment. Ten patients achieved ≥5‐point UPDRS reductions. TNF‐α, IL‐1β, and IL‐6 decreased, whereas IL‐10 increased after treatment. Conclusions: Add‐on duloxetine was associated with changes in clinical outcomes and inflammatory markers in patients with PD.
- Open Access
- 24 February 2026
- Published by Elsevier in SSRN Electronic Journal
Spatiotemporal Macroecological Patterns of Aedes Aegypti and Dengue Fever in a Subtropical Region of Brazil: Seasonal Synchrony of Larval-Positive Sites and Limited Predictive Capacity of Entomological Surveillance
Dengue fever is an increasingly significant public health challenge in subtropical regions. This study investigates the spatiotemporal macroecological patterns of Aedes aegypti infestation and dengue cases in Santa Catarina, Brazil, from 2015 to 2024, to assess the seasonal synchrony of vector infestation and the predictive capacity of entomological surveillance. Using circular statistics, correlation analysis, NMDS ordination, and ARIMAX modeling on data from 17 Health Regions, we identified a highly synchronized seasonal peak in Ae. aegypti positive breeding sites, predominantly in March. However, dengue incidence showed no consistent seasonal pattern. Spatial synchrony in Ae. aegypti PBS occurrence was observed statewide, with the greatest temporal similarity among western regions. On the other hand, the temporal correlation between Ae. aegypti positive breeding sites and dengue cases was weak and heterogeneous; predictive models were significant in only 6 of 17 regions and largely underestimated the major 2024 outbreak. We conclude that while Ae. aegypti infestation is predictably seasonal, the vector larval abundance alone has limited utility for forecasting dengue outbreaks. These results highlight the need for surveillance systems to integrate virological, serological, and climatic data alongside entomological indicators for effective early warning.
- 24 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSpatiotemporal Macroecological Patterns of Aedes Aegypti and Dengue Fever in a Subtropical Region of Brazil: Seasonal Synchrony of Larval-Positive Sites and Limited Predictive Capacity of Entomological Surveillance
Dengue fever is an increasingly significant public health challenge in subtropical regions. This study investigates the spatiotemporal macroecological patterns of Aedes aegypti infestation and dengue cases in Santa Catarina, Brazil, from 2015 to 2024, to assess the seasonal synchrony of vector infestation and the predictive capacity of entomological surveillance. Using circular statistics, correlation analysis, NMDS ordination, and ARIMAX modeling on data from 17 Health Regions, we identified a highly synchronized seasonal peak in Ae. aegypti positive breeding sites, predominantly in March. However, dengue incidence showed no consistent seasonal pattern. Spatial synchrony in Ae. aegypti PBS occurrence was observed statewide, with the greatest temporal similarity among western regions. On the other hand, the temporal correlation between Ae. aegypti positive breeding sites and dengue cases was weak and heterogeneous; predictive models were significant in only 6 of 17 regions and largely underestimated the major 2024 outbreak. We conclude that while Ae. aegypti infestation is predictably seasonal, the vector larval abundance alone has limited utility for forecasting dengue outbreaks. These results highlight the need for surveillance systems to integrate virological, serological, and climatic data alongside entomological indicators for effective early warning.